Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Patient characteristics associated with medication adherence.

Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ.

Clin Med Res. 2013 Jun;11(2):54-65. doi: 10.3121/cmr.2013.1113. Epub 2013 Apr 11.

2.

Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.

Iyengar RN, Balagere DS, Henderson RR, LeFrancois AL, Rabbitt RM, Frazee SG.

J Manag Care Spec Pharm. 2014 Aug;20(8):851-61.

3.

Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.

Spence MM, Makarem AF, Reyes SL, Rosa LL, Nguyen C, Oyekan EA, Kiyohara AT.

J Manag Care Spec Pharm. 2014 Oct;20(10):1036-45.

4.

Unintentional non-adherence to chronic prescription medications: how unintentional is it really?

Gadkari AS, McHorney CA.

BMC Health Serv Res. 2012 Jun 14;12:98. doi: 10.1186/1472-6963-12-98.

5.
6.

Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.

Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP.

J Manag Care Pharm. 2009 Jan-Feb;15(1):32-41.

7.

Impact of Employer-Sponsored Onsite Pharmacy and Condition Management Programs on Medication Adherence.

Aguilar KM, Hou Q, Miller RM.

J Manag Care Spec Pharm. 2015 Aug;21(8):670-7.

8.

The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study.

Han E, Suh DC, Lee SM, Jang S.

Res Social Adm Pharm. 2014 Nov-Dec;10(6):e87-98. doi: 10.1016/j.sapharm.2014.02.001. Epub 2014 Jun 27.

PMID:
25088545
9.

Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension.

Piette JD, Heisler M, Ganoczy D, McCarthy JF, Valenstein M.

Psychiatr Serv. 2007 Feb;58(2):207-12.

PMID:
17287377
10.

Associations between statin adherence level, health care costs, and utilization.

Zhao Y, Zabriski S, Bertram C.

J Manag Care Spec Pharm. 2014 Jul;20(7):703-13.

11.

A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.

Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, Essien EJ, Chung N, Fleming M.

J Manag Care Spec Pharm. 2016 Jan;22(1):63-73. doi: 10.18553/jmcp.2016.22.1.63.

12.

Adherence to Oral Medications for Hypertension and Diabetes in Veterans with Comorbid Airflow Limitation.

Melzer AC, Uman J, Au DH.

Ann Am Thorac Soc. 2015 Jun;12(6):831-7. doi: 10.1513/AnnalsATS.201501-001OC.

13.

Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.

Laliberté F, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS.

Adv Ther. 2012 Aug;29(8):675-90. doi: 10.1007/s12325-012-0040-x. Epub 2012 Aug 15.

PMID:
22898791
14.

Antihypertensive medication adherence in the Department of Veterans Affairs.

Siegel D, Lopez J, Meier J.

Am J Med. 2007 Jan;120(1):26-32.

PMID:
17208076
15.

The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.

Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP.

Med Care. 2010 May;48(5):409-17. doi: 10.1097/MLR.0b013e3181d68978.

PMID:
20393360
16.

Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders.

Raebel MA, Ellis JL, Carroll NM, Bayliss EA, McGinnis B, Schroeder EB, Shetterly S, Xu S, Steiner JF.

J Gen Intern Med. 2012 Jan;27(1):57-64. doi: 10.1007/s11606-011-1829-z. Epub 2011 Aug 31.

17.

Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.

Yang Y, Thumula V, Pace PF, Banahan BF 3rd, Wilkin NE, Lobb WB.

Clin Ther. 2009 Oct;31(10):2178-88; discussion 2150-1. doi: 10.1016/j.clinthera.2009.10.002.

PMID:
19922889
18.

Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims.

McHorney CA, Victor Spain C, Alexander CM, Simmons J.

Clin Ther. 2009 Nov;31(11):2584-607. doi: 10.1016/j.clinthera.2009.11.030.

PMID:
20110004
19.

Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.

Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC.

Curr Med Res Opin. 2009 Sep;25(9):2303-10. doi: 10.1185/03007990903126833.

PMID:
19635045
20.

Pharmacy effect on adherence to antidiabetic medications.

Sharma KP, Taylor TN.

Med Care. 2012 Aug;50(8):685-91. doi: 10.1097/MLR.0b013e318249d800.

PMID:
22354211

Supplemental Content

Support Center